Zhejiang Xianju Pharmaceutical Co.Ltd(002332) ( Zhejiang Xianju Pharmaceutical Co.Ltd(002332) ) said in a recent survey that rocuronium injection was included in the seventh batch of national centralized procurement catalogue, and the company will actively participate in the national drug centralized procurement declaration. The sales of rocuronium bromide injection showed a rapid growth this year due to the promotion of related products such as sodium sugeng glucose (rocuronium antagonist) and other factors.